NeuroLogica GC80 X-ray System Recall: Overexposure Risk in Thorax Scans
NeuroLogica recalls GC80 Digital X-ray Imaging System due to overexposure risk during thorax exams. Affected units may produce unsafe images; contact for details.
Lower-risk recall
An image was obtained with over exposure during a Thorax examination using the AEC function.
Contact the company
What happened, in plain English
NeuroLog: The GC80 Digital X-ray Imaging System is recalled because it can produce overexposed images during thorax exams. This could lead to unnecessary radiation exposure for patients. Affected units have an Accession Number 1310459. Read more at govinfonow.com/recall/73652-neurologica-gc80-x-ray-system-recall-overexposure-risk-in-thorax.
Source Summary by GovInfoNow · govinfonow.com/recall/73652-neurologica-gc80-x-ray-system-recall-overexposure-risk-in-thorax · Updated September 22, 2026 · FDA enforcement record: FDA #Z-0726-2018
Cite this page
“NeuroLogica GC80 X-ray System Recall: Overexposure Risk in Thorax Scans.” GovInfoNow, updated September 22, 2026. https://govinfonow.com/recall/73652-neurologica-gc80-x-ray-system-recall-overexposure-risk-in-thorax. Based on FDA recall #Z-0726-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0726-2018%22&limit=1).
Why it’s dangerous
The system's automatic exposure control (AEC) function can cause overexposure during thorax examinations. This means images may have higher radiation levels than intended, potentially increasing patient radiation exposure.
Who’s affected
Users of the NeuroLogica GC80 Digital X-ray Imaging System with Accession Number 1310459 are affected. Medical facilities using this model for thorax exams are most at risk.
How to tell if you have this one
Check for the Accession Number 1310459 on the GC80 Digital X-ray Imaging System. This model was sold by NeuroLogica Corporation.
- Brand
NeuroLogica- Category
Medical device
What to do — step by step
Check Product Details
Identify the Accession Number 1310459 on your GC80 Digital X-ray Imaging System.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide US” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 15 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-0726-2018 (June 22, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0726-2018 to see it in context.
- Plain-language summary written by qwen3:4b on September 22, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.